Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Innovative DNA technology speeds up TB diagnosis
DNA
Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

Whole Genome Sequencing found to be more effective

Scientists are using innovative DNA technology to diagnose cases of TB up to eight times faster than traditional methods.

A study led by the University of Oxford concludes that Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

The researchers say that the method marks 'a significant milestone' in the way TB is tackled, but the outlook looks even better, as whole genome sequencing technology is set to improve.

Whole Genome Sequencing has been used before in TB research studies, but this is the first time that it has been applied in real world scenarios.

In the study, the researchers were able to detect presence of TB and whether it was resistant to commonly used antibiotics within one week - up to eight times faster than utilising traditional diagnosis methods. 

Furthermore, the fast diagnosis meant the scientists were able to detect and respond to potential outbreaks as they happen.

The method has also proven to be more cost-effective, at an average of £481 per positive case, compared to £517 per case using current technologies.

Lead author Dr Louise Pankhurst from the University of Oxford, said: "This is a really exciting time to be working in infectious disease research. The UK is poised to become the first country in the world to replace traditional tuberculosis diagnosis with whole genome sequencing.

"Our study has shown how this will dramatically speed up the time taken to diagnose TB, helping patients be placed on the most effective treatment as soon as possible and reducing the risk of disease transmission."

The research, Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study is published in the Lancet Respiratory Medicine.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.